Johnson & Johnson, the US pharmaceuticals group, has one month to decide whether to try to claim back full rights over two pivotal medicines as a result of Merck's $41bn planned takeover of Schering Plough
Financial Times - US homepage, Financial Times
Tue, 03/10/2009 - 12:44pm
Johnson & Johnson, the US pharmaceuticals group, has one month to decide whether to try to claim back full rights over two pivotal medicines as a result of Merck's $41bn planned takeover of Schering Plough